Macugen Observational Study

TerminatedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Vascular Endothelial Growth FactorMacular Degeneration
Interventions
OTHER

No intervention

No intervention

Trial Locations (5)

380009

Pfizer Investigational Site, Navrangpura, Ahemdabad

122 002

Pfizer Investigational Site, Gurgaon

682 015

Pfizer Investigational Site, Kochi

400 054

Pfizer Investigational Site, Mumbai

302 004

Pfizer Investigational Site, Jaipur

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY